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cristina.esteves@ed.ac.ukAbstractMurine 3T3-L1 adipocytes are widely used as a cellular model of obesity. However, whereas
transfection of 3T3-L1 preadipocytes is straightforward, ectopic gene expression in mature
3T3-L1 adipocytes has proved challenging. Here, we used the pSLIK vector system to
generate stable doxycycline-inducible expression of the liver-enriched inhibitor protein
isoform of CCAAT/enhancer binding protein b (C/ebpb (Cebpb)) (C/EBPb-LIP) in fully
differentiated 3T3-L1 adipocytes. Because overexpression of C/ebpb-LIP impairs adipocyte
differentiation, the C/ebpb-LIP construct was first integrated in 3T3-L1 preadipocytes but
expression was induced only when adipocytes were fully differentiated. Increased C/EBPb-LIP
in mature adipocytes down-regulated C/ebpb target genes including 11b-hydroxysteroid
dehydrogenase type 1, phosphoenolpyruvate carboxykinase and fatty acid binding protein 4
but had no effect on asparagine synthetase, demonstrating that transcriptional down-
regulation by C/ebpb-LIP in 3T3-L1 adipocytes is not a general effect. Importantly, these
genes were modulated in a similar manner in adipose tissue of mice with genetically
increased C/ebpb-LIP levels. The use of the pSLIK system to conditionally express transgenes
in 3T3-L1 cells could be a valuable tool to dissect adipocyte physiology.Key Words
" adipocyte
" stable transfection
" pSLIK
" C/EBPb-LIPicen
.0 UJournal of Molecular
Endocrinology
(2013) 51, 91–98IntroductionFirst developed almost 40 years ago from Swiss mouse
embryo cells, 3T3-L1 adipocytes (Otto & Lane 2005, Rosen
& MacDougald 2006) have proved to be an invaluable
tool, advancing our understanding of cellular mechanisms
underlying obesity-related disorders. However, introduc-
tion of nucleic acids and, consequently, the manipulation
of genes in fully differentiated 3T3-L1 adipocytes are
difficult to achieve. pSLIK plasmids, encoding a tetra-
cycline-regulated transcriptional unit in a lentivirus-based
vector backbone, were originally designed to facilitatestable transduction of microRNA-like short hairpin RNAs
into RAW264.7 cells (Shin et al. 2006) but have not been
tested in adipocytes.
The transcription factor CCAAT/enhancer binding
protein b (C/ebpb (Cebpb)) is produced as three major
isoforms resulting from differential use of in-frame trans-
lation start sites or from proteolysis (Ossipow et al. 1993,
Welm et al. 1999, Calkhoven et al. 2000); the 38 and 35 kDa
liver-enriched activator protein isoforms (C/ebpb-LAP* and
C/ebpb-LAP respectively) and the 20 kDa liver-enrichedsed under a Creative Commons
nported License.
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51 :1 92inhibitor protein (LIP; C/ebpb-LIP). C/ebpb-LIP contains the
carboxyl-terminal dimerisation and DNA binding domains
but lacks the amino-terminal activation domain of C/ebpb-
LAP (Ramji & Foka 2002). Consequently, C/ebpb-LIP
represses transcription by forming either homodimers or
heterodimers with the C/ebpb-LAP isoforms or other C/ebps
(Descombes et al. 1990, Calkhoven et al. 2000) and
manipulation of C/ebpb-LIP levels may change C/ebpb-
LIP:LAP ratio. However, the majority of reports do not
differentiate between C/ebpb isoforms, and genetic disrup-
tion of the encoding gene eliminates production of all
isoforms. While C/ebpb is well recognised as a major player
in adipocyte differentiation and metabolism, the role of the
specific isoforms, and especially the C/ebpb-LIP isoform, is
less clear. We have recently shown that genetic manipulation
of levels of C/ebpb-LIP in vivo changes adipose tissue
expression of the C/ebpb target gene that encodes the
glucocorticoid amplifying enzyme 11b-hydroxysteroid
dehydrogenase type 1 (11b-hsd1 (Hsd11b1); Seckl et al.
2004, Esteves et al. 2012). However, exploration of
mechanisms in 3T3-L1 adipocytes is hindered by the
impairment of preadipocyte differentiation by C/ebpb-LIP
(Yeh et al. 1995, Payne et al. 2007, Abdou et al. 2011).
Here, we have used the pSLIK system to generate stable
inducible expression of C/ebpb-LIP in 3T3-L1 adipocytes.
Increased levels of C/ebpb-LIP in 3T3-L1 adipocytes
decreased the expression of the metabolically relevant
C/ebpb target genes encoding phosphoenolpyruvate car-
boxykinase (Pepck (Pck1)), fatty acid binding protein 4
(Fabp4) and asparagine synthetase in a manner similar to
manipulation of C/ebpb-LIP in vivo.Materials and methods
Ethics statement
All animal experiments were conducted in strict accord-
ance with internationally accepted standards of humane
animal care following prior approval by the Institutional
Animal Care and Use Committee in Berlin, Germany.
Cells and animals
Murine 3T3-L1 preadipocytes (American Type Culture
Collection (ATCC)) were maintained in DMEM (Lonza,
Cambridge, UK) supplemented with newborn calf serum
(10%; Lonza), unless otherwise stated. Adult male C/ebpb
mutant mice, heterozygous C/ebpb(C/L), homozygous
C/ebpbDuORF and respective wild-type (WT) littermate
control mice (nZ6–7/group) were generated as described
previously (Smink et al. 2009, Wethmar et al. 2010).http://jme.endocrinology-journals.org
DOI: 10.1530/JME-13-0029
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C/ebpb-LIP DNA sequence was excised from pMSV-
C/ebpb (a gift from S L McKnight and W-C Yeh), ligated
to an internal ribosome entry site (IRES) to allow for
downstream GFP expression and the resulting C/ebpb-
LIP-IRES construct was cloned into pMBA-266. C/ebpb-LIP
and control (empty) pSLIK vectors (Shin et al. 2006) were
generated by gateway recombination between a pEN
(MBA-266; ATCC) entry vector harbouring C/ebpb-LIP
or empty vector and the pSLIK-Neo destination vector
(MBA-235; ATCC). 3T3-L1 preadipocytes were transfected
with control or C/ebpb-LIP-expressing pSLIK vectors using
Lipofectamine 2000 (Invitrogen), followed by R15-day
selection of cells resistant to 1 mg/ml geneticin (Invitro-
gen). Transfection efficiency was high (data not shown)
and a total pool of transfected preadipocytes was obtained.
Both control and C/ebpb-LIP transfectants expressed GFP
in the presence of doxycycline (DOX; 1 mg/ml; Sigma) and
were further selected by cell sorting in the presence of
DOX (FACSVantage, BD Biosciences, San Jose, CA, USA).
Preadipocytes were maintained throughout in geneticin.Differentiation of 3T3-L1 preadipocytes into adipocytes
3T3-L1 preadipocytes, cultured in the absence of DOX,
harbouring C/ebpb-LIP or control empty vector, were
induced to differentiate into mature adipocytes as
described previously (Napolitano et al. 1998). Cells were
grown to confluence, and 2 days later, they were induced
to differentiate in DMEM supplemented with 10% FCS,
0.5 mM dexamethasone, 500 mM 3-isobutyl-1-methylxan-
thine and 5 mg/ml insulin for 2 days. Thereafter, 3T3-L1
cell differentiation continued in medium supplemented
with 5 mg/ml insulin alone. Experiments were performed
8–12 days following induction of differentiation, unless
otherwise stated. DOX (1 mg/ml) was added to the medium
in the experiments designed to induce C/ebpb-LIP.Western blot analysis
Cells were harvested in lysis buffer (0.125 M Tris–HCL,
pH 6.8, 2% SDS and 10% glycerol) in the presence of a
protease inhibitor cocktail (P2714; Sigma) and heated
at 100 8C. Electrophoresis was carried out on 4–12%
NuPage Bis–Tris gels (Invitrogen). After transfer, blots
were probed with antibodies to C/EBPb (1:500 dilution
of stock 200 mg/ml; Santa Cruz Biotechnology, Inc.)
and b-tubulin (1:10 000 dilution; Chemicon/Millipore,
Watford, UK). Secondary antibodies were anti-rabbitPublished by Bioscientifica Ltd
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51 :1 93IgG-HRP (1:2000 dilution from stock 400 mg/ml; Santa
Cruz Biotechnology, Inc.), anti-mouse IgG-HRP (1:4000
dilution; Cell Signaling, Danvers, MA, USA), anti-rabbit
IgG Alexa Fluor 700 (Invitrogen) or anti-mouse IgG 488
Conjugated (Rockland Immunochemicals, Inc., Gilbertsville,
PA, USA). The resulting bands were visualised on
X-ray films developed in a Konica SRX-101 X-RayA
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Figure 1
The pSLIK-C/ebpb-LIP construct and generation of stably transfected 3T3-L1
preadipocytes. (A) Schematic representation of the pSLIK Tet-On empty
vector (top; vector, pSLIK) and construct used to generate stable 3T3-L1
preadipocytes conditionally overexpressing C/ebpb-LIP (bottom; LIP, pSLIK-
C/ebpb-LIP). C/ebpb-LIP and GFP are co-expressed from the same transcript.
The constitutively active ubiquitin c (Ubi-c) promoter drives expression of
the Tet activator (rtTA3) and neomycin resistance gene (Neo; for selection).
Addition of DOX causes binding of rtTA3 to the TRE/CMV promoter (TRE),
inducing expression of GFP or C/ebpb-LIP-IRES-GFP. (B) FACS analysis and
sorting of 3T3-L1 preadipocytes (5!106 cells) stably transfected with
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as appropriate.Oil Red O staining
3T3-L1 adipocytes were stained by Oil Red O as described
previously (Lillie & Ashburn 1943) with modifications.After cell sorting
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pSLIK-C/ebpb-LIP (LIP) or pSLIK vector (vector) following DOX treatment
(1 mg/ml, 24 h) to induce GFP. Upper panels, forward scatter (FSC) vs side
scatter (SSC) dot plots, showing the populations of single cells (circled) that
were analysed and sorted for GFP expression (FSC vs GFP intensity plots;
middle row of panels) and histogram showing the number of cells for GFP
intensity (lower panels). Middle and lower panels show the enrichment of
GFP-positive cells for both pSLIK-C/ebpb-LIP and pSLIK cells after sorting
(right panels) resulting from the removal of low or non-GFP-expressing
preadipocytes (arrow; left panels).
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51 :1 94Cells were immersed in isopropanol (60%), followed by the
staining solution (0.04% Oil Red O in 60% isopropanol) and
ammonia (1%) and then visualised using a Zeiss Axioskop
microscope. Quantification of Oil Red O staining density
was performed with ImageJ (NIH, Bethesda, MA, USA).RNA extraction and real-time PCR
Cells were harvested in TRIzol (Invitrogen) and RNA
was extracted according to the manufacturer’s protocol.
Mouse subcutaneous adipose tissue was dissected and
frozen (K70 8C) prior to RNA extraction using Qiagen
RNeasy Lipid Tissue Mini kit (Qiagen). RNA (1 mg) was
reverse transcribed using SuperScript III (Invitrogen),
and specific mRNAs were quantified by real-time PCRLIP
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Figure 2
Doxycycline-inducible expression of C/ebpb-LIP in fully differentiated
adipocytes and adipocyte differentiation visualised by Oil Red O staining.
(A) Western blot showing induction of C/ebpb-LIP expression in 3T3-L1
pSLIK-C/ebpb-LIP (LIP,CDOX) or pSLIK control vector (vector,CDOX)
adipocytes. Preadipocytes were differentiated into adipocytes in DOX-free
medium. Mature adipocytes were then treated with DOX for 2 days. In the
absence of DOX, C/ebpb-LIP levels were not elevated above basal
endogenous levels in pSLIK-C/ebpb-LIP adipocytes (LIP, KDOX). The blot
(40 mg protein/lane) was probed with C/EBPb antibody (38 kDa LAP*,
35 kDa LAP and 20 kDa LIP are indicated), then stripped and reprobed with
b-tubulin antibody, as loading control. All samples in each membrane were
analysed in the same gel, but not in adjacent lanes. (B) Western blot
http://jme.endocrinology-journals.org
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Printed in Great Britainusing a LightCycler 480 (Roche) as described (Sai et al.
2008). Primer–probe sets were purchased from Applied
Biosystems: C/ebpb (Mm00843434_s1), 11b-hsd1
(Mm00476182_m1), Pepck (Mm01247058_m1), Fabp4
(Mm00445878_m1) and asparagine synthetase (Mm
00803785_m1). TATA binding protein (TBP; Mm
00446973_m1) was used as internal control and did not
change with treatment or between groups.Statistical analysis
All data were analysed by Student’s t-test or one-way
ANOVA followed by post hoc least square difference test
using SigmaStat 2.03 Statistical Software. Significance
was set at P%0.05.2 5
–
+DOX–DOX
C LIP
(b)
showing robust induction of C/ebpb-LIP in pSLIK-C/ebpb-LIP adipocytes,
previously differentiated in DOX-free medium and then treated with DOX
between days 0 and 2. Samples (50 mg protein/lane) were taken before
treatment (0), 2 days after DOX-induction of C/ebpb-LIP (2; CDOX) and
2 and 5 days following DOX withdrawal from the medium (2 and 5;KDOX).
(C and D) Oil Red O staining showing lipid accumulation in differentiated
adipocytes. 3T3-L1 pSLIK-C/ebpb-LIP preadipocytes were differentiated into
adipocytes in the presence (CDOX) or absence (KDOX) of DOX (C) or were
differentiated in the absence of DOX and then DOX-treated for 3 days prior
to Oil Red O staining (D). Panels show differentiated adipocytes; pSLIK-
C/ebpb-LIP (LIP; b), pSLIK control vector (vector; a) and untransfected
3T3-L1 adipocytes (c). Objective magnification,!10.
Published by Bioscientifica Ltd
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51 :1 95Results
Conditional expression of C/ebpb-LIP in stably transfected
3T3-L1 preadipocytes and differentiated adipocytes
To generate a vector to conditionally express C/ebpb-LIP,
the encoding cDNA was cloned and recombined in the0
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Printed in Great BritainMBA-266 and the pSLIK-Neo MBA-235 vectors, respectively,
producing the pSLIK-C/ebpb-LIP vector in which a tetra-
cycline response element drives expression of C/ebpb-LIP
from a minimal CMV promoter in the presence of DOX
(a Tet-ON system) and a contiguous IRES allows for GFP
expression. Constitutive expression of the reverse Tet
transactivator (rtTA3) and the neomycin resistance gene
(Neo) is driven by the ubiquitin-c (Ubi-c) promoter (Fig. 1A).
In order to express C/ebpb-LIP in mature adipocytes, we first
generated stably transfected 3T3-L1 preadipocytes that, in
contrast to fully differentiated adipocytes, could be readily
transfected with pSLIK-C/ebpb-LIP or the ‘empty’ vector.
This was highly efficient allowing selection of transfectants
with geneticin as a total pool of cells, avoiding clonal
differences due to plasmid integration site. To ensure that
only transfected cells were used in the subsequent experi-
ments, preadipocytes were sorted by flow cytometry for GFP
expression 24 h after incubation with DOX, with yields of
26 and 56% for pSLIK-C/ebpb-LIP and pSLIK-transfectants
respectively (Fig. 1B). In the absence of DOX, only 0.9% of
pSLIK-C/ebpb-LIP and 4.3% of pSLIK preadipocytes were
GFP positive, demonstrating low spontaneous expression
in the transfected preadipocytes. pSLIK-C/ebpb-LIP preadi-
pocytes were then differentiated into mature adipocytes
in DOX-free medium (to avoid the inhibitory effects of
C/ebpb-LIP upon adipocyte differentiation) and subsequent
DOX treatment robustly increased cellular C/ebpb-LIP levels
in the mature adipocytes (Fig. 2A and B). Following removal
of DOX from the cell medium, C/ebpb-LIP decreased as
expected, showing that it can be transiently induced
(Fig. 2B). Importantly, in the absence of DOX, pSLIK-
C/ebpb-LIP adipocytes showed comparable low endogen-
ous levels of C/ebpb-LIP to control adipocytes harbouring
the pSLIK empty vector (Fig. 2A).Figure 3
Elevated adipocyte C/ebpb-LIP represses expression of C/ebpb-target genes
but not of asparagine synthetase. Real-time PCR measurement of levels of
mRNAs encoding (A) 11b-hsd1, (B) Pepck, (C) Fabp4 and (D) asparagine
synthetase in 3T3-L1 pSLIK-C/ebpb-LIP adipocytes (black bars) compared
with pSLIK control adipocytes (white bars), following 1–4 days of induction
with DOX. Preadipocytes were differentiated into adipocytes in DOX-free
medium and DOX was added to mature adipocytes to induce C/ebpb-LIP
expression. Levels of specific mRNAs, normalised to TBP are expressed
relative to levels in pSLIK adipocytes (arbitrarily set to 100%). Data are
meanGS.E.M. of two independent adipocyte differentiations, each carried
out in triplicate. *Significantly different from pSLIK control adipocytes.
*P%0.05, **P!0.001 and ***P!0.0001.
Published by Bioscientifica Ltd
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51 :1 963T3-L1 preadipocytes stably transfected with
pSLIK-C/ebpb-LIP differentiate normally into adipocytes
Consistent with previous data (Yeh et al. 1995, Payne et al.
2007, Abdou et al. 2011), adipocyte differentiation (demon-
strated by Oil Red O staining of lipid) was markedly
attenuated if C/ebpb-LIP expression was induced in 3T3-L1
pSLIK-C/ebpb-LIP preadipocytes prior to and during
differentiation by DOX (Fig. 2C). In contrast, when pSLIK-
C/ebpb-LIP preadipocytes were differentiated in the absence
of DOX, both pSLIK control and pSLIK-C/ebpb-LIP pre-
adipocytes differentiated normally into mature adipocytes.
Induction of C/ebpb-LIP in fully differentiated adipocytes
had no effect on their differentiation status as shown by
quantification of Oil Red O staining (Fig. 2D).B
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The transcriptional impact of increased C/ebpb-LIP in adipo-
cytes was examined following induction with DOX only once
3T3-L1 adipocytes were fully differentiated. Concurrent with
the increase in C/ebpb-LIP expression, and consequently
C/ebpb-LIP:LAP ratio, DOX reduced Hsd11b1 and Pck1
mRNA levels in 3T3-L1 pSLIK-C/ebpb-LIP adipocytes compa-
red with control cells (Fig. 3A and B). Fabp4mRNA levels were
decreased following 4 days of DOX treatment but asparagine
synthetase mRNA levels were unaffected (Fig. 3C and D).
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Figure 4
Elevated C/ebpb-LIP represses expression of Pck1 and Fabp4, but not
asparagine synthetase in adipose tissue in vivo. Real-time PCR
measurement of levels of mRNA encoding (A) Pepck, (B) Fabp4 and
(C) asparagine synthetase in adipose tissue of wild-type control mice
(Con, white bars), C/ebpb(C/L) (C/L, black bars) and C/ebpbDuORF (DuORF,
grey bars). C/ebpb(C/L) mice are heterozygous for an allele of C/ebpb in
which the normal gene has been replaced by C/ebpb-LIP (a ‘knock-in’;
Smink et al. 2009) and C/ebpbDuORF mice have a homozygous disruption of
the upstream ORF (Wethmar et al. 2010). Adipose tissue mRNA levels,
normalised to TBP, are expressed relative to levels in control mice
(arbitrarily set to 100%) and are meanGS.E.M.; nZ6–9/group. *P%0.05.Modulation of C/ebpb-LIP levels in adipose tissue
in vivo changes the expression of Pepck and Fabp4
To test the relevance of the 3T3-L1 pSLIK-C/ebpb-LIP
adipocyte model to the in vivo situation, we measured the
levels of mRNA encoding Pck1, Fabp4 and asparagine
synthetase in the adipose tissue of mice genetically
engineered to produce altered levels of C/ebpb-LIP,
which we have previously shown to regulate adipose
tissue 11b-hsd1 mRNA levels (Esteves et al. 2012).
C/ebpb(C/L) mice, with a ‘knock-in’ of C/ebpb-LIP (L allele)
replacing the normal C/ebpb gene, have increased C/ebpb-
LIP levels and therefore increased C/ebpb-LIP:LAP ratio
(Smink et al. 2009). In contrast, in C/ebpbDuORF mice,
deletion of the upstream open reading frame (DuORF
allele) prevents translation of C/ebpb-LIP (Wethmar et al.
2010), resulting in decreased C/ebpb-LIP:LAP ratio (Esteves
et al. 2012). In agreement with the results obtained in the
3T3-L1 pSLIK-C/ebpb-LIP adipocytes, levels of mRNA
encoding Pepck were lower in the adipose tissue ofhttp://jme.endocrinology-journals.org
DOI: 10.1530/JME-13-0029
 2013 The authors
Printed in Great BritainC/ebpb(C/L) mice compared with C/ebpbDuORF (Fig. 4A).
However, there was no significant decrease in Pck1 mRNA
levels in C/ebpb(C/L) mice compared with WT controls,
suggesting a larger effect of C/ebpb-LIP in vitro than in vivoPublished by Bioscientifica Ltd
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tissues other than adipose). FABP4 levels were lower in
the adipose of C/ebpb(C/L) mice compared with control
and C/ebpbDuORF mice, while asparagine synthetase was
unchanged (Fig. 4B and C). Taken together, these results
show that the 3T3-L1 pSLIK-C/ebpb-LIP adipocytes mimic
the in vivo regulation.Discussion
The use of the pSLIK system to conditionally express
C/ebpb-LIP in fully differentiated 3T3-L1 mature adipo-
cytes allowed investigating its impact on the transcrip-
tional levels of 11b-hsd1, Pepck, Fabp4 and asparagine
synthetase in these cells. Although transfection of
adipocytes with small RNAs (siRNA and shRNA) has
recently been achieved using nanoparticles of virus-
derived amphipathic peptides (Li et al. 2007, Esteves
et al. 2012), transfection of vectors harbouring expression
cassettes remains a challenge. Electroporation, used in
some studies (Thurmond et al. 1998), causes high levels of
adipocyte death, is inefficient, and requires large amounts
of DNA (or RNA). Adenovirus transduction allows
expression of exogenous genes in 3T3-L1 adipocytes
(Gnudi et al. 1997, Boizard et al. 1998, Duong et al. 2002,
Carlotti et al. 2004) but does not produce stable expression
and can induce immune responses. Many genes expressed
in adipocytes, including 11b-hsd1 (Chapman et al. 2009),
are immunoresponsive (Shoelson et al. 2006). Lentiviral
vectors can be used to stably transduce adipocytes but
require production of high titres of virus (Carlotti et al.
2004, Liao et al. 2006). The pSLIK vector used in the
current study was originally designed as an intermediate
in lentiviral construction (Shin et al. 2006) and combines
all components required for expression (Tet-ON) and
selection (Neo, GFP) in a single plasmid vector. This
allows for the transfection of the pSLIK-C/ebpb-LIP vector
into 3T3-L1 preadipocytes without the need for lentivirus
and proves a highly efficient process. Here, we used DOX
to restrict expression of C/ebpb-LIP to fully differentiated
3T3-L1 adipocytes, but ectopic transgene expression can
be initiated at any stage of 3T3-L1 adipocyte differen-
tiation or even induced transiently. Moreover, it may
prove useful for expression of shRNA in differentiated
adipocytes, to conditionally knockdown gene expression.
Contrary to standard lentiviral transduction of adipocytes,
here, all adipocytes harbour the gene of interest and
expression is achieved soon after induction with DOX.
Elevation of C/ebpb-LIP in mature differentiated 3T3-L1
adipocytes concomitantly decreased Pck1 and Hsd11b1http://jme.endocrinology-journals.org
DOI: 10.1530/JME-13-0029
 2013 The authors
Printed in Great BritainmRNA levels, suggesting direct regulation of 11b-hsd1 by
C/ebpb-LIP in adipocytes. Indeed, both genes are bound
by C/ebpb and this has been shown for 11b-hsd1 in several
cell types (Arai et al. 2007, Sai et al. 2008, Yang et al. 2009),
including adipocytes (Esteves et al. 2012), and for PEPCK in
hepatoma cells (Park et al. 1993, Choudhury et al. 2011).
Pck1 mRNA levels declined faster than other genes, possibly
reflecting the short half-life of PEPCK (Tilghman et al. 1974)
compared withHsd11b1mRNA, for example (Balachandran
et al. 2008). Fabp4 mRNA levels were only affected after
more prolonged elevation of C/ebpb-LIP, suggesting that
either the mRNA is very stable or regulation is indirect.
However, C/ebpb-LIP expression did not depress global
transcription in adipocytes, as asparagine synthetase
mRNA levels were unaffected by elevated adipocyte
C/ebpb-LIP both in vitro and in vivo. This contrasts with the
HepG2 hepatoma cells where asparagine synthase is
regulated by the C/ebpb-LIP:LAP ratio (Siu et al. 2001) and
might reflect differences in epigenetic regulation.
Finally, we note that this system may be of broader
application to explore the role of other adipocyte relevant
genes in fully differentiated adipocytes, providing insights
into their effect on adipocyte physiology.
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